Page 134 - APPENDIX B: Trials Investigating the Management of Acute Radiation-Induced Skin Reactions Reading Qualitative Research
P. 134

132
 WOUND CARE




 3) Thilmann, C.,   Quantifying the increase  Increase of the   1) Type of   1) Silicone- coated polyamid   With electron therapy, the dose   Removal of lesion
 Adamietz, I. A.,   of the dose on the skin   skin dose  wound   net (Mepitel®) 0.5mm thick     increase through a wound   recommended for
 Mose, S., Saran, F.,   through different wound         dressing                 ) Silk acetate (Cuticerin*) 0.4   dressing is small (3-7%).  Any   ulcerating tumor
    2
 Ramm, U., &   dressings during         2) Type of   mm thick (3) Hydrocolloid   of the wound dressings can be   as a low surface
 Bottcher H. D.   irradiation for different         Xray beam   (Varihesive®, extra thin)   left on the skin during electron   dose through high
 (1996).   beam qualities and beam   and                 0.5mm thick (4) Ca- Na-   irradiation, but its thickness   dose build up is
 Increase of surface   energies.    3) quality of   Alginate (Kaltostat®) 2 mm   should be taken into account   not desired.  Not
 dose using wound         beam      thick.         when calculating the actual   clear, if removal of
 dressings during                       applied dose.  With photons the  non-adherent
 percutaneous                           dose increases depending on         wound dressing
 radiotherapy with                      the thickness of its tissue.  The   was intended.
 photons and                            polyamide and silk acetate
 electrons.                             dressings had equal increase in
 Radiotherapy and                       skin dose; a slightly higher skin
 Oncology.                              dose was measured for the
                                        hydrocolloid wound dressing.
                                        For ulcerating tumor, all non-
                                        adhesive wound dressings
                                        whose clinical aptitude for the
                                        treatment of ulcerating tumors
                                        have been proven can be used
                                        regardless of their dosimetric
                                        characteristic.  Wound
                                        dressings can be left on the skin
                                        without increasing the risk of
                                        an aggravated skin reaction.
                                        This has to be taken into
                                        account while calculating the
                                        actual applied dose.
   129   130   131   132   133   134   135   136   137   138   139